Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


20.02.2017

1 Arch Virol
3 BMC Gastroenterol
6 Clin Infect Dis
3 Eur J Gastroenterol Hepatol
1 Gastroenterology
4 Hepatology
3 J Clin Microbiol
5 J Hepatol
2 J Infect Dis
1 J Interferon Cytokine Res
2 J Med Virol
3 J Viral Hepat
1 J Virol
1 JAMA
1 Pediatr Infect Dis J
1 PLoS One
1 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Arch Virol

  1. MUGOSA B, Cella E, Lai A, Lo Presti A, et al
    Hepatitis C virus genotype 3A in a population of injecting drug users in Montenegro: Bayesian and evolutionary analysis.
    Arch Virol. 2017 Feb 13. doi: 10.1007/s00705-017-3224.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  2. ATKIN C, Earwaker P, Pallan A, Shetty S, et al
    Exceptional serological and radiological response to sorafenib in 2 patients with advanced hepatocellular carcinoma and chronic hepatitis C viral infection: case report and review of the literature.
    BMC Gastroenterol. 2017;17:30.
    PubMed     Text format     Abstract available

  3. BOURGEOIS S, Van Vlierberghe H, Moreno C, Orlent H, et al
    Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection.
    BMC Gastroenterol. 2017;17:26.
    PubMed     Text format     Abstract available

  4. MENG Z, Zhang Y, Wei Z, Liu P, et al
    High serum resistin associates with intrahepatic inflammation and necrosis: an index of disease severity for patients with chronic HBV infection.
    BMC Gastroenterol. 2017;17:6.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  5. BEGUELIN C, Friolet N, Moradpour D, Sahli R, et al
    Impact of tenofovir on hepatitis delta virus replication in the Swiss HIV Cohort Study.
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    PubMed     Text format    

  6. YOUNG J, Rossi C, Gill J, Walmsley S, et al
    Risk factors for hepatitis C virus reinfection after sustained virologic response in patients co-infected with HIV.
    Clin Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed     Text format    

  7. BURTON MJ, Naggie S
    Real World Effectiveness of DAA Therapies in HIV/HCV Co-Infection: 996 Veterans Can't Be Wrong.
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    PubMed     Text format    

  8. BHATTACHARYA D, Belperio PS, Shahoumian TA, Loomis TP, et al
    Effectiveness of All-Oral Antiviral Regimens in 996 Genotype 1 HIV/HCV Coinfected Patients Treated in Routine Practice.
    Clin Infect Dis. 2017 Feb 11. doi: 10.1093.
    PubMed     Text format    

  9. BLOCK TM, Locarnini S, McMahon BJ, Rehermann B, et al
    Use of current and new endpoints in the evaluation of experimental hepatitis B therapeutics.
    Clin Infect Dis. 2017 Feb 12. doi: 10.1093.
    PubMed     Text format    

  10. ANDERSON ES, Galbraith JW, Deering LJ, Pfeil SK, et al
    Continuum of Care for HCV Among Patients Diagnosed in the Emergency Department Setting.
    Clin Infect Dis. 2017 Feb 16. doi: 10.1093.
    PubMed     Text format    


    Eur J Gastroenterol Hepatol

  11. SU F, Beste LA, Green PK, Berry K, et al
    Direct-acting antivirals are effective for chronic hepatitis C treatment in elderly patients: a real-world study of 17 487 patients.
    Eur J Gastroenterol Hepatol. 2017 Feb 13. doi: 10.1097/MEG.0000000000000858.
    PubMed     Text format     Abstract available

  12. GAO F, Sun L, Ye X, Liu Y, et al
    Development and validation of a prognostic model for acute-on-chronic hepatitis B liver failure.
    Eur J Gastroenterol Hepatol. 2017 Feb 13. doi: 10.1097/MEG.0000000000000854.
    PubMed     Text format     Abstract available

  13. NORTH CS, Pollio DE, Sims OT, Jain MK, et al
    An effectiveness study of group psychoeducation for hepatitis C patients in community clinics.
    Eur J Gastroenterol Hepatol. 2017 Feb 13. doi: 10.1097/MEG.0000000000000860.
    PubMed     Text format     Abstract available


    Gastroenterology

  14. JACOBSON IM, Lawitz E, Kwo PY, Hezode C, et al
    Safety and Efficacy of Elbasvir/Grazoprevir in Patients with Hepatitis C Virus Infection and Compensated Cirrhosis: an Integrated Analysis.
    Gastroenterology. 2017 Feb 10. pii: S0016-5085(17)30150.
    PubMed     Text format     Abstract available


    Hepatology

  15. XU L, Wang W, Li Y, Zhou X, et al
    RIG-I Is A Key Antiviral Interferon-Stimulated Gene Against Hepatitis E Virus Dispensable Of Interferon Production.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29105.
    PubMed     Text format     Abstract available

  16. LEMPP FA, Wiedtke E, Qu B, Roques P, et al
    Sodium taurocholate cotransporting polypeptide is the limiting host factor of Hepatitis B Virus infection in macaque and pig hepatocytes.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29112.
    PubMed     Text format     Abstract available

  17. BRUDEN DJ, McMahon BJ, Townshend-Bulson L, Gounder P, et al
    Risk of End Stage Liver Disease, Hepatocellular Carcinoma and Liver-Related Death By Fibrosis Stage in the Hepatitis C Alaska Cohort.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29115.
    PubMed     Text format     Abstract available

  18. CHEN G, Wang C, Chen J, Ji D, et al
    Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta-analysis.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29109.
    PubMed     Text format     Abstract available


    J Clin Microbiol

  19. CHEVALIEZ S, Dauvillier C, Dubernet F, Poveda JD, et al
    The New Aptima HBV Quant Real-time TMA Assay Accurately Quantifies Hepatitis B Virus DNA from Genotypes A to F.
    J Clin Microbiol. 2017 Feb 15. pii: JCM.02219-16. doi: 10.1128/JCM.02219.
    PubMed     Text format     Abstract available

  20. MAKIALA-MANDANDA S, Le Gal F, Ngwaka-Matsung N, Ahuka-Mundeke S, et al
    High prevalence and diversity of hepatitis viruses in suspected cases of yellow fever in the Democratic Republic of Congo.
    J Clin Microbiol. 2017 Feb 15. pii: JCM.01847-16. doi: 10.1128/JCM.01847.
    PubMed     Text format     Abstract available

  21. CHAN MC, Kwok K, Hung TN, Chan PK, et al
    Molecular Epidemiology and Strain Comparison between Hepatitis E Virus in Human Sera and Pig Livers during 2014-2016 in Hong Kong.
    J Clin Microbiol. 2017 Feb 15. pii: JCM.02020-16. doi: 10.1128/JCM.02020.
    PubMed     Text format     Abstract available


    J Hepatol

  22. CALLEJA JL, Crespo J, Rincon D, Ruiz-Antoran B, et al
    Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: results from a Spanish real world cohort.
    J Hepatol. 2017 Feb 8. pii: S0168-8278(17)30063.
    PubMed     Text format     Abstract available

  23. ZIMMERMANN R, Kollan C, Ingiliz P, Mauss S, et al
    Real-world treatment for chronic hepatitis C infection in Germany. Analyses from drug prescription data, 2010 - 2015.
    J Hepatol. 2017 Feb 8. pii: S0168-8278(17)30059.
    PubMed     Text format     Abstract available

  24. ZENG QL, Xu GH, Zhang JY, Li W, et al
    Generic ledipasvir-sofosbuvir for patients with chronic hepatitis C: a real-life observational study.
    J Hepatol. 2017 Feb 8. pii: S0168-8278(17)30060.
    PubMed     Text format     Abstract available

  25. CABIBBO G, Petta S, Barbara M, Attardo S, et al
    Hepatic Decompensation is the Major Driver of Death In HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma.
    J Hepatol. 2017 Feb 9. pii: S0168-8278(17)30070.
    PubMed     Text format     Abstract available

  26. OLIVIERO B, Mantovani S, Varchetta S, Mele D, et al
    Hepatitis C virus-Induced NK Cell Activation Causes Metzincin-Mediated CD16 Cleavage and Impaired Antibody-Dependent Cytotoxicity.
    J Hepatol. 2017 Feb 9. pii: S0168-8278(17)30069.
    PubMed     Text format     Abstract available


    J Infect Dis

  27. MANOR Y, Lewis M, Ram D, Daudi N, et al
    Evidence for Hepatitis A Virus Endemic Circulation in Israel Despite Universal Toddler Vaccination Since 1999 and Low Clinical Incidence in All Age Groups.
    J Infect Dis. 2016 Dec 24. doi: 10.1093.
    PubMed     Text format    

  28. ZHOU X, Huang F, Xu L, Lin Z, et al
    Hepatitis E virus infects neurons and brains.
    J Infect Dis. 2017 Feb 11. doi: 10.1093.
    PubMed     Text format    


    J Interferon Cytokine Res

  29. FOUAD R, Zachariah K, Khairy M, Khorshied M, et al
    Single Nucleotide rs760370 Polymorphism at the Main Ribavirin Transporter Gene Detection by PCR-RFLP Assay Compared with the TaqMan Assay and Its Relation to Sustained Virological Response in Chronic HCV Patients Treated with Pegylated Interferon-Riba
    J Interferon Cytokine Res. 2017;37:90-96.
    PubMed     Text format     Abstract available


    J Med Virol

  30. FU X, Chen J, Chen H, Lin J, et al
    Mutation in the S gene of hepatitis B virus and anti-HBs subtype-nonspecificity contributed to the coexistence of HBsAg and anti-HBs in patients with chronic hepatitis B virus infection.
    J Med Virol. 2017 Feb 15. doi: 10.1002/jmv.24782.
    PubMed     Text format     Abstract available

  31. YANG Y, Du D, Jin L, Tian Z, et al
    A molecular epidemiology study investigating familial clustering of hepatitis B virus infection in families with unfavorable prognoses in Northwest China.
    J Med Virol. 2017 Feb 15. doi: 10.1002/jmv.24783.
    PubMed     Text format     Abstract available


    J Viral Hepat

  32. GRANNAN S
    Understanding Patient Perceptions and Risk for Hepatitis C Screening.
    J Viral Hepat. 2017 Feb 15. doi: 10.1111/jvh.12692.
    PubMed     Text format     Abstract available

  33. YONGHAO G, Pumei D, Jianhui Y, Jin X, et al
    A retrospective study of hepatitis B mother-to-child transmission prevention and post-vaccination serological test results of infants at risk of perinatal transmission in two counties of middle China.
    J Viral Hepat. 2017 Feb 15. doi: 10.1111/jvh.12694.
    PubMed     Text format     Abstract available

  34. TAMAKI N, Kurosaki M, Kusakabe A, Orito E, et al
    Hepatitis B Surface Antigen Reduction by Switching from Long-term Nucleoside/nucleotide Analog Administration to Pegylated Interferon.
    J Viral Hepat. 2017 Feb 15. doi: 10.1111/jvh.12691.
    PubMed     Text format     Abstract available


    J Virol

  35. BRAYNE AB, Dearlove BL, Lester JS, Kosakovsky Pond SL, et al
    Genotype-specific evolution of hepatitis E virus.
    J Virol. 2017 Feb 15. pii: JVI.02241-16. doi: 10.1128/JVI.02241.
    PubMed     Text format     Abstract available


    JAMA


  36. Sofosbuvir/Velpatasvir (Epclusa) for Hepatitis C.
    JAMA. 2017;317:639-640.
    PubMed     Text format    


    Pediatr Infect Dis J

  37. CHRISTELLE TX, Min CS, Lee LY, Ong C, et al
    Serologic Responses After Hepatitis B Vaccination in Preterm Infants Born to Hepatitis B Surface Antigen Positive Mothers: Singapore Experience.
    Pediatr Infect Dis J. 2017 Feb 13. doi: 10.1097/INF.0000000000001578.
    PubMed     Text format     Abstract available


    PLoS One

  38. WELSCH C, Efinger M, von Wagner M, Herrmann E, et al
    Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response.
    PLoS One. 2017;12:e0171755.
    PubMed     Text format     Abstract available


    Vaccine

  39. CHAPPUIS F, Farinelli T, Deckx H, Sarnecki M, et al
    Immunogenicity and estimation of antibody persistence following vaccination with an inactivated virosomal hepatitis A vaccine in adults: A 20-year follow-up study.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30080.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: